| Previous Close | 143.50 |
| Open | 143.01 |
| Bid | 142.31 x 0 |
| Ask | 142.34 x 0 |
| Day's Range | 142.13 - 144.30 |
| 52 Week Range | 104.81 - 157.74 |
| Volume | 634,542 |
| Avg. Volume | 280,126 |
| Market Cap | 20.343B |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | 19.75 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.32 (2.33%) |
| Ex-Dividend Date | Mar. 12, 2021 |
| 1y Target Est | N/A |
- CNW Group
In wake of Supreme Court ruling, TekSavvy urges CRTC to immediately implement 2019 wholesale rates and promote affordable internet
As frustrated consumers demand federal action to lower prices, Canada's top court dismisses Big Telecom's case with costs. 25, 2021 /CNW/ - TekSavvy Solutions Inc.
- CNW Group
Intact Financial Corporation Senior Vice President and Chief Financial Officer Louis Marcotte to Speak at the 22nd Annual Credit Suisse Virtual Financial Services Forum
23, 2021 /CNW/ - Louis Marcotte, Senior Vice President and Chief Financial Officer of Intact Financial Corporation (TSX: IFC), will participate in a virtual fireside chat as a part of the 22nd Annual Credit Suisse Virtual Financial Services Forum on Wednesday, February 24, 2021 at 4:20 PM EST.The full video webcast will be archived in the Events and Presentations section of Intact Financial Corporation's website for one year.
- CNW Group
Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy
17, 2021 /CNW/ -- Onward Therapeutics SA (Onward) announced today the execution of a strategic investment in EMERCell SAS, Montpellier, France, a company that has developed a platform technology to produce off-the-shelf natural killer (NK) cells. The undisclosed amounts of the equity investment in three instalments, allow Onward to become the majority shareholder.
